A Study to Evaluate ICP-022 in Patients With R/R Marginal Zone Lymphoma (MZL)
Clinical trial NCT03797456 · COMPLETED
Trial details
- NCT number
- NCT03797456
- Sponsor
- Beijing InnoCare Pharma Tech Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-01
- Primary completion
- 2023-12-27
- Enrollment
- 111
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.